Works by Cheon, Jaekyung

Results: 56

Lenvatinib versus Sorafenib Second-Line Therapy in Patients with Hepatocellular Carcinoma Progressed to Atezolizumab plus Bevacizumab: A Retrospective Real-World Study.

Published in:

Oncology, 2025, v. 103, n. 6, p. 456, doi. 10.1159/000541018

By:

Persano, Mara;
Casadei-Gardini, Andrea;
Tada, Toshifumi;
Suda, Goki;
Shimose, Shigeo;
Kudo, Masatoshi;
Rossari, Federico;
Yoo, Changhoon;
Cheon, Jaekyung;
Finkelmeier, Fabian;
Lim, Ho Yeong;
Presa, José;
Masi, Gianluca;
Bergamo, Francesca;
Amadeo, Elisabeth;
Vitiello, Francesco;
Kumada, Takashi;
Sakamoto, Naoya;
Iwamoto, Hideki;
Aoki, Tomoko

Publication type:

Article

Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 522, doi. 10.1159/000537915

By:

Rossari, Federico;
Tada, Toshifumi;
Suda, Goki;
Shimose, Shigeo;
Kudo, Masatoshi;
Yoo, Changhoon;
Cheon, Jaekyung;
Finkelmeier, Fabian;
Lim, Ho Yeong;
Presa, José;
Masi, Gianluca;
Bergamo, Francesca;
Amadeo, Elisabeth;
Vitiello, Francesco;
Kumada, Takashi;
Sakamoto, Naoya;
Iwamoto, Hideki;
Aoki, Tomoko;
Chon, Hong Jae;
Himmelsbach, Vera

Publication type:

Article

Thyroid Dysfunction after Atezolizumab and Bevacizumab Is Associated with Favorable Outcomes in Hepatocellular Carcinoma.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 89, doi. 10.1159/000531182

By:

Song, Young Shin;
Yang, Hannah;
Kang, Beodeul;
Cheon, Jaekyung;
Kim, Ilhwan;
Kim, Hyeyeong;
Lee, Won Suk;
Sang, Yun Beom;
Jung, Sanghoon;
Lim, Ho Yeong;
Gaillard, Vincent E.;
Kim, Chan;
Chon, Hong Jae

Publication type:

Article

Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 5, p. 613, doi. 10.1159/000508901

By:

Cheon, Jaekyung;
Chon, Hong Jae;
Bang, Yeonghak;
Park, Neung Hwa;
Shin, Jung Woo;
Kim, Kang Mo;
Lee, Han Chu;
Lee, Jooho;
Yoo, Changhoon;
Ryoo, Baek-Yeol

Publication type:

Article

Second-Line Fluoropyrimidine-Based Chemotherapy in Advanced Biliary Tract Cancer: A Meta-analysis Based on Individual Patient-Level Data of Randomized Trials.

Published in:

Cancer Research & Treatment, 2025, v. 57, n. 2, p. 519, doi. 10.4143/crt.2024.652

By:

Hyung, Jaewon;
Kang, Minsu;
Kim, Ilhwan;
Kim, Kyu-pyo;
Ryoo, Baek-Yeol;
Cheon, Jaekyung;
Ryu, Hyewon;
Lee, Ji Sung;
Kim, Ji-Won;
Choi, In Sil;
Park, Jin Hyun;
Abou-Alfa, Ghassan K.;
Kim, Jin Won;
Yoo, Changhoon

Publication type:

Article

Clinical Practice Recommendations for the Use of Next-Generation Sequencing in Patients with Solid Cancer: A Joint Report from KSMO and KSP.

Published in:

Cancer Research & Treatment, 2024, v. 56, n. 3, p. 721, doi. 10.4143/crt.2023.1043

By:

Miso Kim;
Hyo Sup Shim;
Sheehyun Kim;
In Hee Lee;
Jihun Kim;
Shinkyo Yoon;
Hyung-Don Kim;
Inkeun Park;
Jae Ho Jeong;
Changhoon Yoo;
Jaekyung Cheon;
In-Ho Kim;
Jieun Lee;
Sook Hee Hong;
Sehhoon Park;
Hyun Ae Jung;
Jin Won Kim;
Han Jo Kim;
Yongjun Cha;
Sun Min Lim

Publication type:

Article

ARID1A Mutation from Targeted Next-Generation Sequencing Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer.

Published in:

Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1291, doi. 10.4143/crt.2022.1450

By:

Sung Hwan Lee;
Jaekyung Cheon;
Seoyoung Lee;
Beodeul Kang;
Chan Kim;
Hyo Sup Shim;
Young Nyun Park;
Sanghoon Jung;
Sung Hoon Choi;
Hye Jin Choi;
Choong-kun Lee;
Hong Jae Chon

Publication type:

Article

Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group.

Published in:

Cancer Research & Treatment, 2022, v. 54, n. 1, p. 1, doi. 10.4143/crt.2021.1115

By:

Shinkyo Yoon;
Miso Kim;
Yong Sang Hong;
Han Sang Kim;
Seung Tae Kim;
Jihun Kim;
Hongseok Yun;
Changhoon Yoo;
Hee Kyung Ahn;
Hyo Song Kim;
In Hee Lee;
In-Ho Kim;
Inkeun Park;
Jae Ho Jeong;
Jaekyung Cheon;
Jin Won Kim;
Jina Yun;
Sun Min Lim;
Yongjun Cha;
Se Jin Jang

Publication type:

Article

Feasibility Study of Physician Orders for Life-Sustaining Treatment for Patients with Terminal Cancer.

Published in:

Cancer Research & Treatment, 2019, v. 51, n. 4, p. 1632, doi. 10.4143/crt.2019.009

By:

Ho Jung An;
Hyun Jeong Jeon;
Sang Hoon Chun;
Hyun Ae Jung;
Hee Kyung Ahn;
Kyung Hee Lee;
Min-ho Kim;
Ju Hee Kim;
Jaekyung Cheon;
JinShil Kim;
Su-Jin Koh

Publication type:

Article

Conventional Cisplatin-Based Combination Chemotherapy Is Effective in the Treatment of Metastatic Spermatocytic Seminoma with Extensive Rhabdomyosarcomatous Transformation.

Published in:

2015

By:

Yumun Jeong;
Jaekyung Cheon;
Tae-Oh Kim;
Doo-Ho Lim;
Sunpyo Lee;
Young-Mi Cho;
Jun Hyuk Hong;
Jae Lyun Lee

Publication type:

Case Study

The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinoma.

Published in:

Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221113266

By:

Kim, Han Sang;
Kim, Chang Gon;
Hong, Jung Yong;
Kim, Il-hwan;
Kang, Beodeul;
Jung, Sanghoon;
Kim, Chan;
Shin, Sang Joon;
Choi, Hye Jin;
Cheon, Jaekyung;
Chon, Hong Jae;
Lim, Ho Yeong

Publication type:

Article

Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis.

Published in:

Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211035983

By:

Cheon, Jaekyung;
Lee, Choong-kun;
Sang, Yun Beom;
Choi, Hye Jin;
Kim, Min Hwan;
Ji, Jun Ho;
Ko, Kwang Hyun;
Kwon, Chang-Il;
Kim, Dae Jung;
Choi, Sung Hoon;
Kim, Chan;
Kang, Beodeul;
Chon, Hong Jae

Publication type:

Article

Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy.

Published in:

Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211003053

By:

Bang, Kyunghye;
Cheon, Jaekyung;
Jeong, Jae Ho;
Im, Hyeon-Su;
Kim, Kyu-pyo;
Ryoo, Baek-Yeol;
Yoo, Changhoon

Publication type:

Article

Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis.

Published in:

Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211035983

By:

Cheon, Jaekyung;
Lee, Choong-kun;
Sang, Yun Beom;
Choi, Hye Jin;
Kim, Min Hwan;
Ji, Jun Ho;
Ko, Kwang Hyun;
Kwon, Chang-Il;
Kim, Dae Jung;
Choi, Sung Hoon;
Kim, Chan;
Kang, Beodeul;
Chon, Hong Jae

Publication type:

Article

Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy.

Published in:

Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211003053

By:

Bang, Kyunghye;
Cheon, Jaekyung;
Jeong, Jae Ho;
Im, Hyeon-Su;
Kim, Kyu-pyo;
Ryoo, Baek-Yeol;
Yoo, Changhoon

Publication type:

Article

Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis.

Published in:

Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920923424

By:

Chae, Heejung;
Jeong, Hyehyun;
Cheon, Jaekyung;
Chon, Hong Jae;
Ryu, Hyewon;
Kim, Il-Hwan;
Kang, Myoung Joo;
Jeong, Jae Ho;
Ryoo, Baek-Yeol;
Kim, Kyu-pyo;
Yoo, Changhoon

Publication type:

Article

Discussing POLST-facilitated hospice care enrollment in patients with terminal cancer.

Published in:

Supportive Care in Cancer, 2022, v. 30, n. 9, p. 7431, doi. 10.1007/s00520-022-07143-x

By:

An, Ho Jung;
Jeon, Hyun Jeong;
Chun, Sang Hoon;
Jung, Hyun Ae;
Ahn, Hee Kyung;
Lee, Kyung Hee;
Kim, Min-ho;
Hee Kim, Ju;
Cheon, Jaekyung;
Koh, Su-Jin

Publication type:

Article

Pegteograstim prophylaxis for chemotherapy-induced neutropenia and febrile neutropenia: a prospective, observational, postmarketing surveillance study in Korea.

Published in:

Supportive Care in Cancer, 2021, v. 29, n. 9, p. 5383, doi. 10.1007/s00520-021-06127-7

By:

Cheon, Jaekyung;
Im, Hyeon-Su;
Shin, Ho-Jin;
Kim, Inho;
Lee, Won Sik;
Lee, Kyung-Hun;
Park, Seong Kyu;
Kim, Min Kyoung;
Choi, Un Jong;
Kim, Jung Han;
Lee, IlKyun;
Jo, Jae-Cheol

Publication type:

Article

Late complications and quality of life assessment for survivors receiving allogeneic hematopoietic stem cell transplantation.

Published in:

2021

By:

Cheon, Jaekyung;
Lee, Yoo Jin;
Jo, Jae-Cheol;
Kweon, Kukju;
Koh, SuJin;
Min, Young Ju;
Park, Sang-Hyuk;
Lee, Sin-hye;
Kim, Hyo-jin;
Choi, Yunsuk

Publication type:

journal article

High levels of baseline serum IL-10 are associated with reduced clinical benefit from first-line immune checkpoint inhibitor therapy in advanced renal cell carcinoma.

Published in:

Journal of Cancer, 2023, v. 14, n. 6, p. 935, doi. 10.7150/jca.81384

By:

Youngun Kim;
Hannah Yang;
Won Suk Lee;
Jaekyung Cheon;
Yun Beom Sang;
Beodeul Kang;
Hong Jae Chon;
Chan Kim

Publication type:

Article

Real-world experience of safety and effectiveness of regorafenib for treatment of metastatic colorectal cancer, advanced gastrointestinal stromal tumors, and hepatocellular carcinoma: a post-marketing surveillance study in Korea.

Published in:

Journal of Cancer, 2022, v. 13, n. 13, p. 3396, doi. 10.7150/jca.74107

By:

Seung-Hoon Beom;
Ki Beom Bae;
Dae Young Zang;
Joohee Bae;
In Gyu Hwang;
Hye Jin Kang;
In Sook Woo;
Byoung Yong Shim;
Byung-Noe Bae;
Jaekyung Cheon;
Sang-Bo Oh;
Joong-Bae Ahn

Publication type:

Article

Impact of Etiology on Efficacy Outcomes with Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Retrospective Analysis in Asia-Pacific.

Published in:

Targeted Oncology, 2024, v. 19, n. 6, p. 917, doi. 10.1007/s11523-024-01103-7

By:

Kim, Sejin;
Lee, Suat Ying;
Cheon, Jaekyung;
Kim, Hyung-Don;
Park, Young Gyu;
Lee, Joycelyn Jie Xin;
Ryu, Min-Hee;
Ryoo, Baek-Yeol;
Tai, David;
Yoo, Changhoon

Publication type:

Article

Adverse Events as Potential Predictive Factors of Activity in Patients with Advanced HCC Treated with Atezolizumab Plus Bevacizumab.

Published in:

Targeted Oncology, 2024, v. 19, n. 4, p. 645, doi. 10.1007/s11523-024-01061-0

By:

Persano, Mara;
Rimini, Margherita;
Tada, Toshifumi;
Suda, Goki;
Shimose, Shigeo;
Kudo, Masatoshi;
Rossari, Federico;
Yoo, Changhoon;
Cheon, Jaekyung;
Finkelmeier, Fabian;
Lim, Ho Yeong;
Presa, José;
Masi, Gianluca;
Bergamo, Francesca;
Amadeo, Elisabeth;
Vitiello, Francesco;
Kumada, Takashi;
Sakamoto, Naoya;
Iwamoto, Hideki;
Aoki, Tomoko

Publication type:

Article

Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma.

Published in:

Targeted Oncology, 2024, v. 19, n. 1, p. 29, doi. 10.1007/s11523-023-01029-6

By:

Camera, Silvia;
Rimini, Margherita;
Rossari, Federico;
Tada, Toshifumi;
Suda, Goki;
Shimose, Shigeo;
Kudo, Masatoshi;
Yoo, Changhoon;
Cheon, Jaekyung;
Finkelmeier, Fabian;
Lim, Ho Yeong;
Presa, José;
Masi, Gianluca;
Bergamo, Francesca;
Salani, Francesca;
Marseglia, Mariarosaria;
Amadeo, Elisabeth;
Vitiello, Francesco;
Kumada, Takashi;
Sakamoto, Naoya

Publication type:

Article

Real-World Data for Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: How Does Adherence to the IMbrave150 Trial Inclusion Criteria Impact Prognosis?

Published in:

Targeted Oncology, 2023, v. 18, n. 2, p. 221, doi. 10.1007/s11523-023-00953-x

By:

Rimini, Margherita;
Persano, Mara;
Tada, Toshifumi;
Suda, Goki;
Shimose, Shigeo;
Kudo, Masatoshi;
Cheon, Jaekyung;
Finkelmeier, Fabian;
Lim, Ho Yeong;
Presa, José;
Masi, Gianluca;
Yoo, Changhoon;
Lonardi, Sara;
Piscaglia, Fabio;
Kumada, Takashi;
Sakamoto, Naoya;
Iwamoto, Hideki;
Aoki, Tomoko;
Chon, Hong Jae;
Himmelsbach, Vera

Publication type:

Article

ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab.

Published in:

Journal of Hepatocellular Carcinoma, 2025, v. 12, p. 671, doi. 10.2147/JHC.S462701

By:

Stefanini, Bernardo;
Fulgenzi, Claudia Angela Maria;
Scheiner, Bernhard;
Korolewicz, James;
Cheon, Jaekyung;
Nishida, Naoshi;
Ang, Celina;
Marron, Thomas U;
Wu, Y Linda;
Saeed, Anwaar;
Wietharn, Brooke;
Rimassa, Lorenza;
Pirozzi, Angelo;
Cammarota, Antonella;
Pressiani, Tiziana;
Pinter, Matthias;
Balcar, Lorenz;
Huang, Yi-Hsiang;
Mehan, Aman;
Phen, Samuel

Publication type:

Article

Deep learning model enables the discovery of a novel immunotherapeutic agent regulating the kynurenine pathway.

Published in:

OncoImmunology, 2021, v. 10, n. 1, p. 1, doi. 10.1080/2162402X.2021.2005280

By:

Jeong Hun Kim;
Won Suk Lee;
Hye Jin Lee;
Hannah Yang;
Seung Joon Lee;
So Jung Kong;
Soyeon Je;
Hyun-Jin Yang;
Jongsun Jung;
Jaekyung Cheon;
Beodeul Kang;
Hong Jae Chon;
Chan Kim

Publication type:

Article

Changes in decision-making process for life-sustaining treatment in patients with advanced cancer after the life-sustaining treatment decisions-making act.

Published in:

BMC Palliative Care, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12904-021-00759-6

By:

Kim, Hyeyeong;
Im, Hyeon-Su;
Lee, Kyong Og;
Min, Young Joo;
Jo, Jae-Cheol;
Choi, Yunsuk;
Lee, Yoo Jin;
Kang, Daseul;
Kim, Changyoung;
Koh, Su-Jin;
Cheon, Jaekyung

Publication type:

Article

Unmet needs related to the quality of life of advanced cancer patients in Korea: a qualitative study.

Published in:

BMC Palliative Care, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12904-021-00749-8

By:

Pyo, Jeehee;
Ock, Minsu;
Lee, Mina;
Kim, Juhee;
Cheon, Jaekyung;
Cho, Juhee;
Kwon, Jung Hye;
Kim, Hyeyeoung;
Im, Hyeon-Su;
Min, Young Joo;
Koh, Su-Jin

Publication type:

Article

CD45dimCD34+CD38-CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia.

Published in:

2020

By:

Heo, Sook-Kyoung;
Noh, Eui-Kyu;
Ju, Lan Jeong;
Sung, Jun Young;
Jeong, Yoo Kyung;
Cheon, Jaekyung;
Koh, Su Jin;
Min, Young Joo;
Choi, Yunsuk;
Jo, Jae-Cheol

Publication type:

journal article

Lenvatinib versus sorafenib as second-line therapy following progression on atezolizumab–bevacizumab in patients with unresectable hepatocellular carcinoma: a multicenter retrospective study from Korea and Japan.

Published in:

Journal of Cancer Research & Clinical Oncology, 2025, v. 151, n. 2, p. 1, doi. 10.1007/s00432-025-06085-1

By:

Cheon, Jaekyung;
Shimose, Shigeo;
Kim, Hyung-Don;
Niizeki, Takashi;
Ryu, Min-Hee;
Shirono, Tomotake;
Ryoo, Baek-Yeol;
Iwamoto, Hideki;
Yoo, Changhoon

Publication type:

Article

Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7565, doi. 10.1007/s00432-023-04678-2

By:

Rimini, Margherita;
Persano, Mara;
Tada, Toshifumi;
Suda, Goki;
Shimose, Shigeo;
Kudo, Masatoshi;
Cheon, Jaekyung;
Finkelmeier, Fabian;
Lim, Ho Yeong;
Presa, José;
Salani, Francesca;
Lonardi, Sara;
Piscaglia, Fabio;
Kumada, Takashi;
Sakamoto, Naoya;
Iwamoto, Hideki;
Aoki, Tomoko;
Chon, Hong Jae;
Himmelsbach, Vera;
Schirripa, Marta

Publication type:

Article

Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 5591, doi. 10.1007/s00432-022-04512-1

By:

Persano, Mara;
Rimini, Margherita;
Tada, Toshifumi;
Suda, Goki;
Shimose, Shigeo;
Kudo, Masatoshi;
Cheon, Jaekyung;
Finkelmeier, Fabian;
Lim, Ho Yeong;
Rimassa, Lorenza;
Presa, José;
Masi, Gianluca;
Yoo, Changhoon;
Lonardi, Sara;
Tovoli, Francesco;
Kumada, Takashi;
Sakamoto, Naoya;
Iwamoto, Hideki;
Aoki, Tomoko;
Chon, Hong Jae

Publication type:

Article

Serum 25‐Hydroxyvitamin D Levels and Survival Outcomes in Advanced Biliary Tract Cancer: Results From the NIFTY Trial.

Published in:

Cancer Medicine, 2025, v. 14, n. 1, p. 1, doi. 10.1002/cam4.70560

By:

Lee, So Heun;
Cheon, Jaekyung;
Kim, Ilhwan;
Kim, Kyu‐pyo;
Ryoo, Baek‐Yeol;
Jeong, Jae Ho;
Kang, Myoung Joo;
Kang, Byung Woog;
Ryu, Hyewon;
Lee, Ji Sung;
Yoo, Changhoon

Publication type:

Article

Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment.

Published in:

Cancer Medicine, 2023, v. 12, n. 3, p. 2731, doi. 10.1002/cam4.5161

By:

Chon, Young Eun;
Cheon, Jaekyung;
Kim, Hyeyeong;
Kang, Beodeul;
Ha, Yeonjung;
Kim, Do young;
Hwang, Seong Gyu;
Chon, Hong Jae;
Kim, Beom Kyung

Publication type:

Article

Atezolizumab plus bevacizumab in patients with child–Pugh B advanced hepatocellular carcinoma.

Published in:

Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359221148541

By:

Cheon, Jaekyung;
Kim, Hyeyeong;
Kim, Han Sang;
Kim, Chang Gon;
Kim, Ilhwan;
Kang, Beodeul;
Kim, Chan;
Jung, Sanghoon;
Ha, Yeonjung;
Chon, Hong Jae

Publication type:

Article

Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death.

Published in:

2020

By:

Heo, Sook-Kyoung;
Noh, Eui-Kyu;
Yu, Ho-Min;
Kim, Do Kyoung;
Seo, Hye Jin;
Lee, Yoo Jin;
Cheon, Jaekyung;
Koh, Su Jin;
Min, Young Joo;
Choi, Yunsuk;
Jo, Jae-Cheol

Publication type:

journal article

Organ‐specific responses to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma: A multicentre, retrospective study.

Published in:

Liver International, 2024, v. 44, n. 8, p. 1961, doi. 10.1111/liv.15935

By:

Cheon, Jaekyung;
Jung, Sanghoon;
Kim, Jung Sun;
Kang, Beodeul;
Kim, Hyeyoung;
Chan, Landon L.;
Becker, Lars;
Gaillard, Vincent E.;
Chan, Stephen L.;
Kim, Chan;
Chon, Hong Jae

Publication type:

Article

Efficacy and safety of atezolizumab plus bevacizumab in Korean patients with advanced hepatocellular carcinoma.

Published in:

Liver International, 2022, v. 42, n. 3, p. 674, doi. 10.1111/liv.15102

By:

Cheon, Jaekyung;
Yoo, Changhoon;
Hong, Jung Yong;
Kim, Han Sang;
Lee, Dae‐Won;
Lee, Myung Ah;
Kim, Jin Won;
Kim, Ilhwan;
Oh, Sang‐Bo;
Hwang, Jun‐Eul;
Chon, Hong Jae;
Lim, Ho Yeong

Publication type:

Article

Regorafenib in patients with advanced Child‐Pugh B hepatocellular carcinoma: A multicentre retrospective study.

Published in:

Liver International, 2020, v. 40, n. 10, p. 2544, doi. 10.1111/liv.14573

By:

Kim, Hyung‐Don;
Bang, Yeonghak;
Lee, Myung Ah;
Kim, Jin Won;
Kim, Jee Hyun;
Chon, Hong Jae;
Kang, Beodeul;
Kang, Myoung Joo;
Kim, Ilhwan;
Cheon, Jaekyung;
Hwang, Jun‐Eul;
Kang, Jung Hun;
Byeon, Seonggyu;
Hong, Jung Yong;
Ryoo, Baek‐Yeol;
Lim, Ho Yeong;
Yoo, Changhoon

Publication type:

Article

Regorafenib in previously treated advanced hepatocellular carcinoma: Impact of prior immunotherapy and adverse events.

Published in:

Liver International, 2020, v. 40, n. 9, p. 2263, doi. 10.1111/liv.14496

By:

Yoo, Changhoon;
Byeon, Seonggyu;
Bang, Yeonghak;
Cheon, Jaekyung;
Kim, Jin W.;
Kim, Jee H.;
Chon, Hong J.;
Kang, Beodeul;
Kang, Myoung J.;
Kim, Ilhwan;
Hwang, Jun‐Eul;
Kang, Jung H.;
Lee, Myung A.;
Hong, Jung Y.;
Lim, Ho Y.;
Ryoo, Baek‐Yeol

Publication type:

Article

Association between HER2 heterogeneity and clinical outcomes of HER2-positive gastric cancer patients treated with trastuzumab.

Published in:

Gastric Cancer, 2022, v. 25, n. 4, p. 794, doi. 10.1007/s10120-022-01298-6

By:

Bang, Kyunghye;
Cheon, Jaekyung;
Park, Young Soo;
Kim, Hyung-Don;
Ryu, Min-Hee;
Park, Yangsoon;
Moon, Meesun;
Lee, Hyungeun;
Kang, Yoon-Koo

Publication type:

Article

Early Integrated Palliative Care in Patients With Advanced Cancer: A Randomized Clinical Trial.

Published in:

JAMA Network Open, 2024, v. 7, n. 8, p. e2426304, doi. 10.1001/jamanetworkopen.2024.26304

By:

Kang, EunKyo;
Kang, Jung Hun;
Koh, Su-Jin;
Kim, Yu Jung;
Seo, Seyoung;
Kim, Jung Hoon;
Cheon, Jaekyung;
Kang, Eun Joo;
Song, Eun-Kee;
Nam, Eun Mi;
Oh, Ho-Suk;
Choi, Hye Jin;
Kwon, Jung Hye;
Bae, Woo Kyun;
Lee, Jeong Eun;
Jung, Kyung Hae;
Yun, Young Ho

Publication type:

Article

Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy.

Published in:

Cancers, 2025, v. 17, n. 11, p. 1797, doi. 10.3390/cancers17111797

By:

Yu, James;
Laborde, Jose M.;
Park, Robin;
Shahzad, Moazzam;
Kim, Youngchul;
Cheon, Jaekyung;
Imanirad, Iman;
Kim, Richard D.;
Biachi de Castria, Tiago;
Nardella, Nicole L.;
Malafa, Mokenge;
Denbo, Jason W.;
Fleming, Jason B.;
Hoffe, Sarah E.;
Frakes, Jessica M.;
Sinnamon, Andrew J.;
Pimiento, Jose M.;
Hodul, Pamela J.;
Kim, Dae Won

Publication type:

Article

High Serum Levels of IL-6 Predict Poor Responses in Patients Treated with Pembrolizumab plus Axitinib for Advanced Renal Cell Carcinoma.

Published in:

Cancers, 2022, v. 14, n. 23, p. 5985, doi. 10.3390/cancers14235985

By:

Sang, Yun Beom;
Yang, Hannah;
Lee, Won Suk;
Lee, Seung Joon;
Kim, Seul-Gi;
Cheon, Jaekyung;
Kang, Beodeul;
Kim, Chang Woo;
Chon, Hong Jae;
Kim, Chan

Publication type:

Article

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.

Published in:

Cancers, 2022, v. 14, n. 23, p. 5834, doi. 10.3390/cancers14235834

By:

Wu, Yue Linda;
Fulgenzi, Claudia Angela Maria;
D'Alessio, Antonio;
Cheon, Jaekyung;
Nishida, Naoshi;
Saeed, Anwaar;
Wietharn, Brooke;
Cammarota, Antonella;
Pressiani, Tiziana;
Personeni, Nicola;
Pinter, Matthias;
Scheiner, Bernhard;
Balcar, Lorenz;
Huang, Yi-Hsiang;
Phen, Samuel;
Naqash, Abdul Rafeh;
Vivaldi, Caterina;
Salani, Francesca;
Masi, Gianluca;
Bettinger, Dominik

Publication type:

Article

Atezolizumab/Bevacizumab vs. Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Real-World, Multi-Center Study.

Published in:

Cancers, 2022, v. 14, n. 7, p. 1747, doi. 10.3390/cancers14071747

By:

Kim, Beom Kyung;
Cheon, Jaekyung;
Kim, Hyeyeong;
Kang, Beodeul;
Ha, Yeonjung;
Kim, Do Young;
Hwang, Seong Gyu;
Chon, Young Eun;
Chon, Hong Jae

Publication type:

Article

Experience and perspectives of end-of-life care discussion and physician orders for life-sustaining treatment of Korea (POLST-K): a cross-sectional study.

Published in:

BMC Medical Ethics, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s12910-023-00897-x

By:

Im, Hyeon-Su;
Lee, Insook;
Kim, Shinmi;
Lee, Jong Soo;
Kim, Ju-Hee;
Moon, Jae Young;
Park, Byung Kyu;
Lee, Kyung Hee;
Lee, Myung Ah;
Han, Sanghoon;
Hong, Yoonki;
Kim, Hyeyeoung;
Cheon, Jaekyung;
Koh, Su-Jin

Publication type:

Article

"Teachable Moment": Effects of an Educational Program on Knowledge and Quality of Life of Korean Breast Cancer Survivors.

Published in:

Journal of Cancer Education, 2022, v. 37, n. 3, p. 812, doi. 10.1007/s13187-020-01888-x

By:

Cheon, Jaekyung;
Choi, Yunsuk;
Kim, Jin Sung;
Ko, Byung Kyun;
Kim, Chung Reen;
Kim, Ju Hee;
Koh, Su-Jin

Publication type:

Article

α‐FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma.

Published in:

International Journal of Cancer, 2024, v. 154, n. 6, p. 1043, doi. 10.1002/ijc.34799

By:

Rossari, Federico;
Tada, Toshifumi;
Suda, Goki;
Shimose, Shigeo;
Kudo, Masatoshi;
Yoo, Changhoon;
Cheon, Jaekyung;
Finkelmeier, Fabian;
Lim, Ho Yeong;
Presa, José;
Masi, Gianluca;
Bergamo, Francesca;
Amadeo, Elisabeth;
Vitiello, Francesco;
Kumada, Takashi;
Sakamoto, Naoya;
Iwamoto, Hideki;
Aoki, Tomoko;
Chon, Hong Jae;
Himmelsbach, Vera

Publication type:

Article